Lysophosphatidic Acid Prevents Apoptosis of Caco-2 Colon Cancer Cells Via Activation of Mitogen-activated Protein Kinase and Phosphorylation of Bad

Overview

Journal Biochim Biophys Acta

Specialties Biochemistry
Biophysics

Date 2007 Jun 5

PMID 17544220

Citations 20

Authors

Raluca Rusovici

Amr Ghaleb

Hyunsuk Shim

Vincent W Yang

C Chris Yun

Affiliations

Soon will be listed here.

Abstract

Lysophosphatidic acids (LPA) exert growth factor-like effects through specific G protein-coupled receptors. The presence of different LPA receptors often determines the specific signaling mechanisms and the physiological consequences of LPA in different environments. Among the four members of the LPA receptor family, LPA(2) has been shown to be overexpressed in colon cancer suggesting that the signaling by LPA(2) may potentiate growth and survival of tumor cells. In this study, we examined the effect of LPA on survival of colon cancer cells using Caco-2 cells as a cell model system. LPA rescued Caco-2 cells from apoptosis elicited by the chemotherapeutic drug, etoposide. This protection was accompanied by abrogation of etoposide-induced stimulation of caspase activity via a mechanism dependent on Erk and PI3K. In contrast, perturbation of cellular signaling mediated by the LPA(2) receptor by knockdown of a scaffold protein NHERF2 abrogated the protective effect of LPA. Etoposide decreased the expression of Bcl-2, which was reversed by LPA. Etoposide decreased the phosphorylation level of the proapoptotic protein Bad in an Erk-dependent manner, without changing Bad expression. We further show that LPA treatment resulted in delayed activation of Erk. These results indicate that LPA protects Caco-2 cells from apoptotic insult by a mechanism involving Erk, Bad, and Bcl-2.

Citing Articles

Identification of biomarkers for the diagnosis in colorectal polyps and metabolic dysfunction-associated steatohepatitis (MASH) by bioinformatics analysis and machine learning.

Geng Y, Li Y, Liu G, Jiao J Sci Rep. 2024; 14(1):29463.

PMID: 39604470 PMC: 11603146. DOI: 10.1038/s41598-024-81120-8.

Autotaxin-Lysophosphatidate Axis: Promoter of Cancer Development and Possible Therapeutic Implications.

Laface C, Ricci A, Vallarelli S, Ostuni C, Rizzo A, Ambrogio F Int J Mol Sci. 2024; 25(14).

PMID: 39062979 PMC: 11277072. DOI: 10.3390/ijms25147737.

Compensatory Upregulation of LPA and Activation of the PI3K-Akt Pathway Prevent LPA-Dependent Loss of Intestinal Epithelial Cells in Intestinal Organoids.

Liang Z, Yun C Cells. 2022; 11(14).

PMID: 35883686 PMC: 9324510. DOI: 10.3390/cells11142243.

Lipid Phosphate Phosphatases and Cancer.

Tang X, Brindley D Biomolecules. 2020; 10(9).

PMID: 32887262 PMC: 7564803. DOI: 10.3390/biom10091263.

Lysophosphatidic Acid and Autotaxin-associated Effects on the Initiation and Progression of Colorectal Cancer.

Yun C Cancers (Basel). 2019; 11(7).

PMID: 31323936 PMC: 6678549. DOI: 10.3390/cancers11070958.

References

Leong M, Maiyar A, Kim B, OKeeffe B, Firestone G . Expression of the serum- and glucocorticoid-inducible protein kinase, Sgk, is a cell survival response to multiple types of environmental stress stimuli in mammary epithelial cells. J Biol Chem. 2002; 278(8):5871-82. DOI: 10.1074/jbc.M211649200. View

Deng W, Wang D, Gosmanova E, Johnson L, Tigyi G . LPA protects intestinal epithelial cells from apoptosis by inhibiting the mitochondrial pathway. Am J Physiol Gastrointest Liver Physiol. 2003; 284(5):G821-9. DOI: 10.1152/ajpgi.00406.2002. View

Noguchi K, Ishii S, Shimizu T . Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J Biol Chem. 2003; 278(28):25600-6. DOI: 10.1074/jbc.M302648200. View

Zhang Y, Hong Y, Bounhar Y, Blacker M, Roucou X, Tounekti O . p75 neurotrophin receptor protects primary cultures of human neurons against extracellular amyloid beta peptide cytotoxicity. J Neurosci. 2003; 23(19):7385-94. PMC: 6740455. View

Tigyi G, Parrill A . Molecular mechanisms of lysophosphatidic acid action. Prog Lipid Res. 2003; 42(6):498-526. DOI: 10.1016/s0163-7827(03)00035-3. View

Ishikawa Y, Kusaka E, Enokido Y, Ikeuchi T, Hatanaka H . Regulation of Bax translocation through phosphorylation at Ser-70 of Bcl-2 by MAP kinase in NO-induced neuronal apoptosis. Mol Cell Neurosci. 2003; 24(2):451-9. DOI: 10.1016/s1044-7431(03)00203-3. View

Lee-Kwon W, Kim J, Choi J, Kawano K, Cha B, Dartt D . Ca2+-dependent inhibition of NHE3 requires PKC alpha which binds to E3KARP to decrease surface NHE3 containing plasma membrane complexes. Am J Physiol Cell Physiol. 2003; 285(6):C1527-36. DOI: 10.1152/ajpcell.00017.2003. View

Miller R, Leanza C, Phillips E, Blacquire K . Homocysteine-induced changes in brain membrane composition correlate with increased brain caspase-3 activities and reduced chick embryo viability. Comp Biochem Physiol B Biochem Mol Biol. 2003; 136(3):521-32. DOI: 10.1016/s1096-4959(03)00277-x. View

Harnois C, Demers M, Bouchard V, Vallee K, Gagne D, Fujita N . Human intestinal epithelial crypt cell survival and death: Complex modulations of Bcl-2 homologs by Fak, PI3-K/Akt-1, MEK/Erk, and p38 signaling pathways. J Cell Physiol. 2003; 198(2):209-22. DOI: 10.1002/jcp.10399. View

10.

Cory S, Huang D, Adams J . The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene. 2003; 22(53):8590-607. DOI: 10.1038/sj.onc.1207102. View

11.

Skurk C, Maatz H, Kim H, Yang J, Abid M, Aird W . The Akt-regulated forkhead transcription factor FOXO3a controls endothelial cell viability through modulation of the caspase-8 inhibitor FLIP. J Biol Chem. 2003; 279(2):1513-25. DOI: 10.1074/jbc.M304736200. View

12.

Yamada T, Sato K, Komachi M, Malchinkhuu E, Tobo M, Kimura T . Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1. J Biol Chem. 2003; 279(8):6595-605. DOI: 10.1074/jbc.M308133200. View

13.

Xu J, Lai Y, Lin W, Lin F . TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor. J Biol Chem. 2003; 279(11):10459-68. PMC: 3904432. DOI: 10.1074/jbc.M311891200. View

14.

Oh Y, Jo N, Choi J, Kim H, Seo S, Kang K . NHERF2 specifically interacts with LPA2 receptor and defines the specificity and efficiency of receptor-mediated phospholipase C-beta3 activation. Mol Cell Biol. 2004; 24(11):5069-79. PMC: 416407. DOI: 10.1128/MCB.24.11.5069-5079.2004. View

15.

Fernando R, Wimalasena J . Estradiol abrogates apoptosis in breast cancer cells through inactivation of BAD: Ras-dependent nongenomic pathways requiring signaling through ERK and Akt. Mol Biol Cell. 2004; 15(7):3266-84. PMC: 452582. DOI: 10.1091/mbc.e03-11-0823. View

16.

Wang Q, Liu M, Kozasa T, Rothstein J, Sternweis P, Neubig R . Thrombin and lysophosphatidic acid receptors utilize distinct rhoGEFs in prostate cancer cells. J Biol Chem. 2004; 279(28):28831-4. DOI: 10.1074/jbc.C400105200. View

17.

Shida D, Watanabe T, Aoki J, Hama K, Kitayama J, Sonoda H . Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer. Lab Invest. 2004; 84(10):1352-62. DOI: 10.1038/labinvest.3700146. View

18.

Dufour G, Demers M, Gagne D, Dydensborg A, Teller I, Bouchard V . Human intestinal epithelial cell survival and anoikis. Differentiation state-distinct regulation and roles of protein kinase B/Akt isoforms. J Biol Chem. 2004; 279(42):44113-22. DOI: 10.1074/jbc.M405323200. View

19.

Mills G, May C, Hill M, Campbell S, Shaw P, Marks A . Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells. J Clin Invest. 1990; 86(3):851-5. PMC: 296802. DOI: 10.1172/JCI114784. View

20.

Yang E, Zha J, Jockel J, Boise L, Thompson C, Korsmeyer S . Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell. 1995; 80(2):285-91. DOI: 10.1016/0092-8674(95)90411-5. View